Status:
UNKNOWN
Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study
Lead Sponsor:
Mansoura University
Conditions:
Overactive Bladder
Botulinum Toxin
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
We hypothesize that LESWs might temporarily increase urothelial permeability and facilitate delivery of intravesical botulinum toxin without the need for injection.
Detailed Description
High energy extracorporeal shock wave thrapy has been used to disintegrate urolithiasis for 30 years (Chaussy et al., 1982). Low energy shock wave LESWs are used clinically to improve tissue regenerat...
Eligibility Criteria
Inclusion
- OAB refractory to treatment with antimuscarinics for 2 months
Exclusion
- Sensitivity to botox
- Neurogenic detrusor overactivity
- Active UTI
Key Trial Info
Start Date :
January 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03385460
Start Date
January 24 2017
End Date
January 1 2019
Last Update
December 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and nephrology center
Al Mansurah, Egypt, 35516